Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A Legal Win For Vaccine Industry: Federal Court Finds No Link To Autism

Executive Summary

After poring over more than 600 medical journal articles, dozens of expert reports, and testimony from a long line of witnesses, a federal court has concluded that there is no link between vaccines and autism in three test cases

You may also be interested in...



Vaccine Makers Win Autism Case; But With Petitions Blocked, Could Suits Rise?

Vaccine manufacturers won another victory when a federal court once again concluded that there is no link between vaccines and autism. The decision will likely eliminate thousands of petitions for compensation from the government, which could in turn lead to more lawsuits against manufacturers

Vaccine Makers Win Autism Case; But With Petitions Blocked, Could Suits Rise?

Vaccine manufacturers won another victory when a federal court once again concluded that there is no link between vaccines and autism. The decision will likely eliminate thousands of petitions for compensation from the government, which could in turn lead to more lawsuits against manufacturers

Vaccine Liability Question Is Urgent, Gov't. Says; Supreme Court Takes Up Case

At the encouragement of the government, the U.S. Supreme Court agreed to take up the question of whether a federal law shields vaccine manufacturers from all liability for alleged vaccine design defects

Related Content

Topics

UsernamePublicRestriction

Register

PS050676

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel